58
Participants
Start Date
September 28, 2023
Primary Completion Date
March 1, 2027
Study Completion Date
March 1, 2027
Biopsy Procedure
Undergo biopsy
Biospecimen Collection
Undergo collection of blood samples
Computed Tomography
Undergo CT scan
Magnetic Resonance Imaging
Undergo MRI
Temozolomide
Given orally (PO)
Tuvusertib
Given PO
RECRUITING
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
RECRUITING
National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RECRUITING
Vanderbilt University/Ingram Cancer Center, Nashville
RECRUITING
Memorial Hospital East, Shiloh
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Siteman Cancer Center-South County, St Louis
RECRUITING
Siteman Cancer Center at Christian Hospital, St Louis
RECRUITING
Siteman Cancer Center at West County Hospital, Creve Coeur
RECRUITING
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
RECRUITING
University of Kansas Cancer Center - Lee's Summit, Lee's Summit
SUSPENDED
University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City
RECRUITING
University of Kansas Cancer Center - North, Kansas City
RECRUITING
University of Kansas Cancer Center, Kansas City
RECRUITING
University of Kansas Clinical Research Center, Fairway
RECRUITING
University of Kansas Hospital-Westwood Cancer Center, Westwood
RECRUITING
University of Kansas Cancer Center-Overland Park, Overland Park
RECRUITING
University of Kansas Hospital-Indian Creek Campus, Overland Park
RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
ACTIVE_NOT_RECRUITING
UC San Diego Moores Cancer Center, La Jolla
RECRUITING
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
RECRUITING
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
RECRUITING
Yale University, New Haven
RECRUITING
Smilow Cancer Hospital Care Center-Trumbull, Trumbull
National Cancer Institute (NCI)
NIH